Kit and method for detecting human leucocyte antigen HLA-B*1502 genetype
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- 瀚吉康生物科技(北京)有限公司
- Publication Date
- 2014-07-09
- Estimated Expiration
- Not applicable · inactive patent
Smart Images
Figure 1 Figure 2 Figure 3
Abstract
Description
technical field
[0001] The invention relates to the field of biology, in particular to a kit and a method for detecting the genotype of human leukocyte antigen HLA-B*1502. Background technique
[0002] Carbamazepine is a tricyclic anticonvulsant widely used in the treatment of epilepsy, trigeminal neuralgia, and manic depression. As the drug is widely used, its adverse reactions are increasingly prominent. The milder adverse reactions are maculopapular exanthema-MPE, including Stevens-Johnson syndrome-SJS, Toxic epidermal necrolysis-TEN, drug hypersensitivity syndrome(HSS) Other serious adverse reactions can be life-threatening.
[0003] Clinical pharmacogenomics studies have linked carbamazepine-induced SJS-TEN to human leukocyte antigen HLA-B*1502 genotype. In recent years, pharmacogenomics has covered different countries and regions in Asia, such as Taiwan, Hong Kong, Thailand, South Korea, Japan, and China. These studies found that 94.1-100% of patients with SJS-TEN ...